Depression Clinical Trials in Chicago, IL

41 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	2 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	2 mi
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	2 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	2 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	2 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	2 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	2 mi
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)	Phase 3	Definium Therapeutics US, Inc.	2 mi
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans	N/A	University of Illinois at Chicago	2 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder	Phase 2	Janssen Research & Development, LLC	2 mi
Perinatal Depression and Adverse Childhood Experiences: Prevention Trial	N/A	Northwestern University	2 mi
Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older	N/A	University of Illinois at Chicago	2 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	2 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	2 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)	—	Janssen Research & Development, LLC	2 mi
Our Voices Matter: Intervention for Depression in Youth	N/A	Ann & Robert H Lurie Children's Hospital of Chicago	2 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	2 mi
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services	—	Beth Israel Deaconess Medical Center	2 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	2 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	2 mi
Antidepressant Effects of Nitrous Oxide	Phase 2	University of Chicago	2 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	2 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	2 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	2 mi
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults	Phase 2	Autobahn Therapeutics, Inc.	2 mi
Mood Effects of Serotonin Agonists: Depression	Early 1	University of Chicago	2 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	2 mi
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)	Phase 3	Cybin IRL Limited	2 mi
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life	N/A	Northwestern University	2 mi
Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families	N/A	University of Illinois at Chicago	2 mi
Test of Target Engagement of Ambiguity Aversion	N/A	Northwestern University	2 mi
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss	N/A	The Chicago Lighthouse	2 mi
Feasibility Testing a Meditation App for Professionals Working With Youth in the Legal System	N/A	University of Illinois at Chicago	2 mi
Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)	N/A	Northwestern University	2 mi
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis	N/A	University of Illinois at Chicago	2 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	2 mi
Optimizing Suicide Prevention Strategies for Pediatric Primary Care	N/A	University of Pittsburgh	21 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	21 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	35 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	35 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder	Phase 2	Sirtsei Pharmaceuticals, Inc.	35 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.